DeLuca, 48, will take the reins on Sept. 15 from former president of Merck Animal Health Raul Kohan, who decided to retire from the company. Kohan will remain with Merck Animal Health through the end of the year to assist with the transition process.
“This is a wonderful time to join Merck, with its commitment to growing its animal health business,” DeLuca said. “I look forward to working with the talented managers and employees in ensuring that the division is a best-in-class global animal health leader."
DeLuca previously served as chief financial officer of BD Biosciences and prior to that was president of Wyeth’s Fort Dodge Animal Health division. In his new role, DeLuca “will leverage the division’s strong product portfolio and customer focus to capitalize on new growth opportunities, including expanding the business in emerging markets,” the company reported.
“We believe [Merck Animal Health] is well positioned in a number of fast-growing segments within the global animal health market,” said Merck president and CEO Kenneth Frazier.